These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1464512)

  • 1. Real-time dynamics of an extravascular magnetic resonance contrast medium in acutely infarcted myocardium using inversion recovery and gradient-recalled echo-planar imaging.
    Yu KK; Saeed M; Wendland MF; Derugin N; Cavagna FM; Higgins CB
    Invest Radiol; 1992 Nov; 27(11):927-34. PubMed ID: 1464512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of myocardial reperfusion with echo planar magnetic resonance imaging. Discrimination between occlusive and reperfused infarctions.
    Saeed M; Wendland MF; Yu KK; Lauerma K; Li HT; Derugin N; Cavagna FM; Higgins CB
    Circulation; 1994 Sep; 90(3):1492-501. PubMed ID: 7522135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI.
    Wendland MF; Saeed M; Lauerma K; Derugin N; Mintorovitch J; Cavagna FM; Higgins CB
    Magn Reson Med; 1997 Mar; 37(3):448-56. PubMed ID: 9055236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depiction of reperfused myocardial infarction using contrast-enhanced spin echo and gradient echo magnetic resonance imaging.
    Geschwind JF; Saeed M; Wendland MF; Higgins CB
    Invest Radiol; 1998 Jul; 33(7):386-92. PubMed ID: 9659590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of acute myocardial infarction with dysprosium DTPA-BMA: influence of dose of magnetic susceptibility contrast medium.
    Saeed M; Wendland MF; Yu KK; Higgins CB
    J Am Coll Cardiol; 1992 Dec; 20(7):1634-41. PubMed ID: 1452938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA.
    Holman ER; van Rossum AC; Doesburg T; van der Wall EE; de Roos A; Visser CA
    Magn Reson Imaging; 1996; 14(1):21-9. PubMed ID: 8656987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-BOPTA for assessment of myocardial viability on MRI: changes of T1 value and their impact on delayed enhancement.
    Krombach GA; Hahnen C; Lodemann KP; Krämer N; Schoth F; Neizel M; Boeringer J; Günther RW; Kelm M; Kühl H
    Eur Radiol; 2009 Sep; 19(9):2136-46. PubMed ID: 19373470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial delayed enhancement using a single dose (0.1 mmol/kg) of gadobenate dimeglumine: contrast resolution versus intraventricular blood and viable myocardium.
    Papini GD; Tritella S; Secchi F; Aliprandi A; Di Leo G; Sardanelli F
    Radiol Med; 2010 Aug; 115(5):693-701. PubMed ID: 20221713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA.
    Doltra A; Skorin A; Hamdan A; Schnackenburg B; Gebker R; Klein C; Nagel E; Fleck E; Kelle S
    Eur Radiol; 2014 Sep; 24(9):2192-200. PubMed ID: 24828537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra low-dose of gadobenate dimeglumine for late gadolinium enhancement (LGE) imaging in acute myocardial infarction: a feasibility study.
    Galea N; Francone M; Zaccagna F; Ciolina F; Cannata D; Algeri E; Agati L; Catalano C; Carbone I
    Eur J Radiol; 2014 Dec; 83(12):2151-2158. PubMed ID: 25293818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gd-BOPTA/Dimeg: experimental disease imaging.
    Cavagna F; Daprà M; Maggioni F; de Haën C; Felder E
    Magn Reson Med; 1991 Dec; 22(2):329-33; discussion 343-6. PubMed ID: 1812366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echo-planar MR imaging of normal and ischemic myocardium with gadodiamide injection.
    Wendland MF; Saeed M; Masui T; Derugin N; Moseley ME; Higgins CB
    Radiology; 1993 Feb; 186(2):535-42. PubMed ID: 8421761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery angiography and myocardial viability imaging: a 3.0-T contrast-enhanced magnetic resonance coronary artery angiography with Gd-BOPTA.
    Yun H; Jin H; Yang S; Huang D; Chen ZW; Zeng MS
    Int J Cardiovasc Imaging; 2014 Jan; 30(1):99-108. PubMed ID: 24068575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging.
    Saeed M; Higgins CB; Geschwind JF; Wendland MF
    Eur Radiol; 2000; 10(2):310-8. PubMed ID: 10663763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
    Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
    AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of contrast-enhanced magnetic resonance imaging to define ischemic injury after reperfusion. Comparison in normal and hypertrophied hearts.
    Lauerma K; Saeed M; Wendland MF; Derugin N; Yu KK; Higgins CB
    Invest Radiol; 1994 May; 29(5):527-35. PubMed ID: 8077091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.